191 related articles for article (PubMed ID: 21913330)
1. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
Gonçalves GA; Bower DM; Prazeres DM; Monteiro GA; Prather KL
Biotechnol J; 2012 Feb; 7(2):251-61. PubMed ID: 21913330
[TBL] [Abstract][Full Text] [Related]
2. Engineering of bacterial strains and vectors for the production of plasmid DNA.
Bower DM; Prather KL
Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
[TBL] [Abstract][Full Text] [Related]
3. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing.
Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM
J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846
[TBL] [Abstract][Full Text] [Related]
4. Biomedical application of plasmid DNA in gene therapy: a new challenge for chromatography.
Sousa F; Passarinha L; Queiroz JA
Biotechnol Genet Eng Rev; 2010; 26():83-116. PubMed ID: 21415877
[TBL] [Abstract][Full Text] [Related]
5. Engineering of Escherichia coli strains for plasmid biopharmaceutical production: scale-up challenges.
Gonçalves GA; Prather KL; Monteiro GA; Prazeres DM
Vaccine; 2014 May; 32(24):2847-50. PubMed ID: 24598722
[TBL] [Abstract][Full Text] [Related]
6. Use FACS sorting in metabolic engineering of Escherichia coli for increased peptide production.
Cheng Q; Ruebling-Jass K; Zhang J; Chen Q; Croker KM
Methods Mol Biol; 2012; 834():177-96. PubMed ID: 22144360
[TBL] [Abstract][Full Text] [Related]
7. Enhanced production of plasmid DNA by engineered Escherichia coli strains.
Pablos TE; Soto R; Mora EM; Le Borgne S; Ramírez OT; Gosset G; Lara AR
J Biotechnol; 2012 Apr; 158(4):211-4. PubMed ID: 21718724
[TBL] [Abstract][Full Text] [Related]
8. Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression.
Carnes AE; Luke JM; Vincent JM; Schukar A; Anderson S; Hodgson CP; Williams JA
Biotechnol Bioeng; 2011 Feb; 108(2):354-63. PubMed ID: 20830679
[TBL] [Abstract][Full Text] [Related]
9. De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production.
Gonçalves GA; Prazeres DM; Monteiro GA; Prather KL
Appl Microbiol Biotechnol; 2013 Jan; 97(2):611-20. PubMed ID: 22885693
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA fermentation strategies: influence on plasmid stability and cell physiology.
Silva F; Queiroz JA; Domingues FC
Appl Microbiol Biotechnol; 2012 Mar; 93(6):2571-80. PubMed ID: 22089386
[TBL] [Abstract][Full Text] [Related]
11. Plasmid DNA production for therapeutic applications.
Lara AR; Ramírez OT; Wunderlich M
Methods Mol Biol; 2012; 824():271-303. PubMed ID: 22160904
[TBL] [Abstract][Full Text] [Related]
12. Marker-free plasmids for gene therapeutic applications--lack of antibiotic resistance gene substantially improves the manufacturing process.
Mairhofer J; Cserjan-Puschmann M; Striedner G; Nöbauer K; Razzazi-Fazeli E; Grabherr R
J Biotechnol; 2010 Apr; 146(3):130-7. PubMed ID: 20138928
[TBL] [Abstract][Full Text] [Related]
13. Plasmid size can affect the ability of Escherichia coli to produce high-quality plasmids.
Yang J; Yang Y
Biotechnol Lett; 2012 Nov; 34(11):2017-22. PubMed ID: 22782268
[TBL] [Abstract][Full Text] [Related]
14. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography.
Sousa F; Prazeres DM; Queiroz JA
J Gene Med; 2009 Jan; 11(1):79-88. PubMed ID: 19021136
[TBL] [Abstract][Full Text] [Related]
15. Enhanced plasmid DNA production by enzyme-controlled glucose release and an engineered Escherichia coli.
Ramírez EA; Velázquez D; Lara AR
Biotechnol Lett; 2016 Apr; 38(4):651-7. PubMed ID: 26696535
[TBL] [Abstract][Full Text] [Related]
16. Successful application of monolithic innovative technology using a carbonyldiimidazole disk to purify supercoiled plasmid DNA suitable for pharmaceutical applications.
Sousa A; Tomaz CT; Sousa F; Queiroz JA
J Chromatogr A; 2011 Nov; 1218(46):8333-43. PubMed ID: 21995857
[TBL] [Abstract][Full Text] [Related]
17. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha).
Phue JN; Lee SJ; Trinh L; Shiloach J
Biotechnol Bioeng; 2008 Nov; 101(4):831-6. PubMed ID: 18814292
[TBL] [Abstract][Full Text] [Related]
18. Growth medium selection and its economic impact on plasmid DNA production.
Danquah MK; Forde GM
J Biosci Bioeng; 2007 Dec; 104(6):490-7. PubMed ID: 18215636
[TBL] [Abstract][Full Text] [Related]
19. Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.
Borja GM; Meza Mora E; Barrón B; Gosset G; Ramírez OT; Lara AR
Microb Cell Fact; 2012 Sep; 11():132. PubMed ID: 22992433
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of plasmid DNA yields during fed-batch culture of a fruR-knockout Escherichia coli strain.
Ow DS; Yap MG; Oh SK
Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):53-9. PubMed ID: 18380624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
